Pulmonary Hypertension Associated with Sickle Cell Disease
📧 Sign up to get email alerts when something new happens for Pulmonary Hypertension Associated with Sickle Cell Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-04-11Clinical Trial Update: Study to Evaluate Efficacy and Safety of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Sickle Cell Disease (SCD) [Phase 3]
A Phase 3 trial evaluating oral treprostinil for pulmonary hypertension in patients with sickle cell disease has been withdrawn.